InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,702.55
(
-0.19%
)
US TECH 100
19,287.60
(
-0.24%
)
Dow Jones
42,063.36
(
0.09%
)
Brent Oil
74.14
(
0.00%
)
Bitcoin
62,803.27
(
-0.90%
)
Post# of 20
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Steve1HD1

Send PM Follow Ignore
Followers 2
Posts 236
Boards Moderated 0
Alias Born 12/08/2011

Steve1HD1

Re: None

Thursday, 04/14/2016 3:26:31 AM

Thursday, April 14, 2016 3:26:31 AM

Post# of 20
"We are excited by the FDA's decision to approve Epi proColon as the first and only blood-based colorectal cancer screening test," Epigenomics CEO and CFO Thomas Taapken said in a statement.



> https://www.genomeweb.com/molecular-diagnostics/fda-approves-epigenomics-blood-based-colorectal-cancer-screening-test
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up